Watch Steven J. O’Day, M.D., Executive Director of the Saint John’s Cancer Institute and Cancer Clinic, and Director of Providence Los Angeles Regional Research, discusses the rationale for using Imprime PGG to trigger immunity and possibly enhance response to pembrolizumab in patients with metastatic triple-negative breast cancer.
Steven J. O’Day, M.D., Executive Director of the Saint John’s Cancer Institute and Cancer Clinic, and Director of Providence Los Angeles Regional Research, presented: Triple-Negative Breast Cancer: Clinical Benefit With Pembrolizumab Plus Imprime PGG at the AACR Annual Meeting. Watch his virtual presentation to learn the results.
NBC4 interviewed Dr. Steven O’Day about the antiviral drug remdesivir and its preliminary data which shows hospitalized patients with COVID-19 who received remdesivir recovered faster than similar patients who received placebo. Watch the interview to learn more.
Dr. Mary Garland-Kledzik, Surgical Oncology Fellow at Saint John’s Cancer Institute, will be presenting key findings at the Digestive Disease Week conference. Learn more about her presentation entitled: Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive surgery and Heated Intraperitoneal Chemotherapy.
Dr. Steven O’Day, M.D., joins host Christina Pascucci from KTLA5, to talk about some of the clinical trials that are taking place to combat COVID-19. Listen to the podcast to learn about some of the more promising drugs researchers are looking at that could get us closer to solving this crisis.
Many young people’s lives are affected by brain cancer. The Sean Hunter Research in Action Bowl fundraiser raise awareness and funds for brain cancer research at the Saint John’s Cancer Institute under the direction of Dr. Santosh Kesari.
Our urologic oncology surgeons, Timothy G. Wilson, M.D., Professor & Chair of Urologic Oncology, and Jennifer Linehan, M.D., Associate Professor of Urologic Oncology, presented at the 4th Annual NARUS North American Robotic Urology Symposium on February 6 – 8, 2020 about the latest advancements and techniques of robotic surgery for prostate and bladder cancer.
PARP inhibitor therapy: A paradigm shift in the treatment of metastatic castration resistant prostate cancer
Przemyslaw Twardowski M.D., Professor of Medical Oncology presented at the Hong Kong Society of Uro-oncology Scientific Meeting. Learn about his presentation findings for prostate cancer treatment.
Venkata Yenugonda, Ph.D., Associate Professor in the Department of Translational Neurosciences, and Director of Drug Discovery and Nanomedicine Research Program at Saint John’s Cancer Institute, presented at the 2019 San Antonio Breast Cancer Symposium®. Learn more about his poster presentation: Small Molecule Targeting Regulated Cell Death Pathways in Treating Triple Negative Breast Cancer.
Marlon Saria, Ph.D, RN, AOCNS, FAAN, oncology clinical nurse specialist, nurse researcher, and director of Neuroscience Quality and Outcomes Research…